admin – Page 3335 – Get News Story

First Rate Roofing and Chimney Expands Services Across All 21 New Jersey Counties Following Headquarters Relocation

First Rate Roofing and Chimney, a trusted family-owned business with three decades of experience in the roofing and chimney industry, has announced a major geographic expansion. With the relocation of its headquarters from Edgewater, NJ to Paramus, NJ, the company is now equipped to serve all 21 counties across the state.

Previously operating primarily in Northern New Jersey, including Bergen, Essex, Hudson, Middlesex, Morris, Passaic, Somerset, Sussex, and Union counties, First Rate Roofing and Chimney’s strategic move to Paramus allows improved access and operational efficiency for projects statewide. This marks a significant milestone for the company, which began as a small roofing installation service in 1995.

“Our relocation positions us at the center of the state, which allows us to respond faster and serve a much broader customer base,” said a company spokesperson. “Homeowners and businesses from Cherry Hill to Sussex can now benefit from our full range of services.”

First Rate Roofing and Chimney offers comprehensive roofing and chimney services including inspection, installation, repairs, and replacements. Their certified professionals specialize in both traditional and flat roofs, chimney liner installation, chimney cleaning, masonry repairs, and siding. They also provide annual chimney inspections in compliance with fire codes and the recommendations of the Chimney Safety Institute of America.

The company is known for its hands-on approach. From the initial inspection to final implementation, their technicians provide clients with detailed evaluations, style and material options, and ongoing project updates. The team emphasizes code compliance and minimal disruption to homeowners throughout each project.

“By expanding our reach to all of New Jersey, we’re meeting the growing demand for quality, licensed contractors who can safely manage chimney flues, fireplace repairs, and other structural maintenance,” the spokesperson added. “With aging homes across the state and increased focus on home safety, certified chimney services are more important than ever.”

First Rate Roofing and Chimney also continues to operate its offices in Glen Rock and Edgewater, ensuring clients in Northern New Jersey still receive the same level of service and quick response times. The new Paramus location, situated at 777 Decker Place, serves as the central hub for logistics and customer service operations statewide.

The company remains fully licensed and insured, with a focus on safety, transparency, and delivering quality work at competitive prices. As they broaden their service area, First Rate Roofing and Chimney is also emphasizing the importance of regular chimney inspections, especially ahead of the colder months when fireplaces and heating systems are in heavier use.

For more information or to request a free estimate, customers can visit www.firstrateroof.com or call (551) 282-9536.

Media Contact
Company Name: First Rate Roofing and Chimney
Contact Person: David Scott
Email: Send Email
Country: United Kingdom
Website: https://firstrateroof.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: First Rate Roofing and Chimney Expands Services Across All 21 New Jersey Counties Following Headquarters Relocation

At Large PR Named Honoree in the 31st Annual Communicator Awards Agency Recognized for Excellence in Creative and Strategic Communication

At Large PR is proud to announce its recognition as an Honoree in the 31st Annual Communicator Awards, presented by the Academy of Interactive & Visual Arts (AIVA).

At Large PR Named Honoree in the 31st Annual Communicator Awards Agency Recognized for Excellence in Creative and Strategic Communication

At Large PR is proud to announce its recognition as an Honoree in the 31st Annual Communicator Awards, presented by the Academy of Interactive & Visual Arts (AIVA). This honor places the agency among the world’s top creators and storytellers in marketing and communications.

The Communicator Awards is the leading international awards program celebrating excellence, effectiveness, and innovation across all areas of communication. With over 3,000 entries received from across the globe, At Large PR’s recognition as an Honoree underscores its commitment to powerful, purpose-driven storytelling and strategic vision.

“We’re honored to be recognized by such a respected institution,” said Jeff Bearden, co-founder of At Large PR. “This award is a testament to the meaningful work we do for our clients and the creative collaboration that drives everything we produce.”

Over its 31-year history, the Communicator Awards has spotlighted outstanding achievement in marketing, branding, advertising, and design. Winners and Honorees are hand-selected by the Academy of Interactive & Visual Arts, a distinguished group of industry-leading professionals from organizations such as Warner Bros. Discovery, Spotify, Disney, and more.

This award connects At Large PR to a global community of creative leaders and innovators, celebrating work that not only looks exceptional but drives results.

For more information on the Communicator Awards, visit www.communicatorawards.com.

About At Large PR

At Large PR is a boutique public relations and brand storytelling agency. Known for its dynamic and personalized approach, At Large PR partners with creatives, businesses, and thought leaders to craft narratives that resonate. From strategy to spotlight, the agency helps clients shape perception, build presence, and make a lasting impact.

Media Contact
Company Name: At Large PR
Contact Person: Jeff Bearden
Email: Send Email
Country: United States
Website: www.atlargepr.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: At Large PR Named Honoree in the 31st Annual Communicator Awards Agency Recognized for Excellence in Creative and Strategic Communication

Metastatic Colorectal Cancer Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Daiichi Sankyo Company, Mirati Therapeutics, Apollomics, Treos

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Metastatic Colorectal Cancer pipeline constitutes 150+ key companies continuously working towards developing 180+ Metastatic Colorectal Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

“Metastatic Colorectal Cancer Pipeline Insight, 2025“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Metastatic Colorectal Cancer Market.

The Metastatic Colorectal Cancer Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Metastatic Colorectal Cancer Pipeline Report:

Companies across the globe are diligently working toward developing novel Metastatic Colorectal Cancer treatment therapies with a considerable amount of success over the years.
Metastatic Colorectal Cancer companies working in the treatment market are Plus Therapeutics, Processa Pharmaceuticals, Shanghai Henlius Biotech, Genor Biopharma, Novartis Pharmaceutical, Sumitomo Pharma Oncology, Purple Biotech Ltd., Nektar Therapeutics, ALX Oncology Inc., Sunshine Guojian Pharmaceutical, Daiichi Sankyo, Gritstone Bio, Inc, Suzhou Suncadia Biopharmaceuti cals Co., Ltd, Amgen, G1 Therapeutic s, Inc., and others, are developing therapies for the Metastatic Colorectal Cancer treatment

Emerging Metastatic Colorectal Cancer therapies in the different phases of clinical trials are- 188RNL-BAM, PCS11T, HLX13, Geptanolimab, HDM201, TP-1454, NT219, NKTR-255, Evorpacept (ALX148), CPGJ 602, Trastuzumab deruxtecan, GRT-C901, SHR-1701, Lumakras (sotorasib), Trilaciclib, and others are expected to have a significant impact on the Metastatic Colorectal Cancer market in the coming years.
In April 2025, Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotech firm focused on PLK1 inhibition to create innovative cancer treatments, has announced that patient enrollment is now complete for its ongoing Phase 2 CRDF-004 trial. The study is assessing the efficacy of onvansertib in combination with standard-of-care therapy for treating first-line RAS-mutated metastatic colorectal cancer (mCRC).
In February 2025, Pfizer’s combination therapy for metastatic colorectal cancer (mCRC) achieved one of its primary goals—significantly improving progression-free survival (PFS)—in a Phase III clinical trial, strengthening the case for full regulatory approval. The active-controlled, open-label BREAKWATER study (NCT05217446) assessed a regimen combining Pfizer’s Braftovi (encorafenib), Eli Lilly’s Erbitux (cetuximab), and mFOLFOX6 (fluorouracil, leucovorin, and oxaliplatin). The therapy was evaluated in previously untreated mCRC patients with a BRAF V600E mutation and successfully met one of its dual primary endpoints by demonstrating improved PFS.
In November 2024, Tizona Therapeutics has broadened its ongoing Phase Ib clinical trial of TTX-080, a novel antibody targeting human leukocyte antigen-G (HLA-G), to include patients with biomarker-defined metastatic colorectal cancer (mCRC).
In September 2024, FRUZAQLA® (fruquintinib) is a kinase inhibitor approved for the treatment of adults with metastatic colorectal cancer (mCRC). This innovative oral treatment is designed for once-daily use, providing a non-chemotherapy alternative for patients who have previously received specific anti-cancer therapies. These may include chemotherapy regimens based on fluoropyrimidine, oxaliplatin, and irinotecan, as well as anti-vascular endothelial growth factor (VEGF) therapy.
In January 2024, Bold Therapeutics, a biopharmaceutical company in the clinical stage, shared favorable results from Phase 2 trials assessing the safety and effectiveness of BOLD-100 in combination with FOLFOX. These trials focused on patients with advanced metastatic colorectal cancer who had previously received treatment with FOLFOX/CAPOX. The findings were presented at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium held from January 18 to 20, 2024.

Metastatic Colorectal Cancer Overview

Metastatic colorectal cancer refers to a stage of colorectal cancer where cancer cells have spread from the primary site (the colon or rectum) to other parts of the body, forming secondary tumors. Colorectal cancer typically starts as a growth of tissue (polyp) in the lining of the colon or rectum and may progress through various stages, with metastatic or advanced stages indicating a more widespread and severe condition.

Get a Free Sample PDF Report to know more about Metastatic Colorectal Cancer Pipeline Therapeutic Assessment-

https://www.delveinsight.com/report-store/metastatic-colorectal-cancer-pipeline-insight

Emerging Metastatic Colorectal Cancer Drugs Under Different Phases of Clinical Development Include:

188RNL-BAM: Plus Therapeutics
PCS11T: Processa Pharmaceutic als
HLX13: Shanghai Henlius Biotech
Geptanolimab: Genor Biopharma
HDM201: Novartis Pharmaceutical
TP-1454: Sumitomo Pharma Oncology
NT219: Purple Biotech Ltd.
NKTR-255: Nektar Therapeutics
Evorpacept (ALX148): ALX Oncology Inc.
CPGJ 602: Sunshine Guojian Pharmaceutic al
Trastuzumab deruxtecan: Daiichi Sanky
GRT-C901: Gritstone Bio, Inc
SHR-1701: Suzhou Suncadia Biopharmaceuti cals Co., Ltd
Lumakras (sotorasib): Amgen
Trilaciclib: G1 Therapeutic s, Inc.

Metastatic Colorectal Cancer Route of Administration

Metastatic Colorectal Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as

Oral
Parenteral
Intravenous
Subcutaneous
Topical

Metastatic Colorectal Cancer Molecule Type

Metastatic Colorectal Cancer Products have been categorized under various Molecule types, such as

Monoclonal Antibody
Peptides
Polymer
Small molecule
Gene therapy

Metastatic Colorectal Cancer Pipeline Therapeutics Assessment

Metastatic Colorectal Cancer Assessment by Product Type
Metastatic Colorectal Cancer By Stage and Product Type
Metastatic Colorectal Cancer Assessment by Route of Administration
Metastatic Colorectal Cancer By Stage and Route of Administration
Metastatic Colorectal Cancer Assessment by Molecule Type
Metastatic Colorectal Cancer by Stage and Molecule Type

DelveInsight’s Metastatic Colorectal Cancer Report covers around 180+ products under different phases of clinical development like

Late-stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I)
Pre-clinical and Discovery stage candidates
Discontinued & Inactive candidates
Route of Administration

Further Metastatic Colorectal Cancer product details are provided in the report. Download the Metastatic Colorectal Cancer pipeline report to learn more about the emerging Metastatic Colorectal Cancer therapies

Some of the key companies in the Metastatic Colorectal Cancer Therapeutics Market include:

Key companies developing therapies for Metastatic Colorectal Cancer are – Daiichi Sankyo Company, Mirati Therapeutics, Apollomics, Treos Bio Zrt, AskAt, Effector Therapeutics, Menarini Group, ImmunityBio, Arcus Biosciences, Abraxis Bioscience, Chia Tai Tianqing Pharmaceutical Group, Aadi, LLC, BioNTech SE, Novartis, Immunovative Therapies, Transgene, Cardiff Oncology, Genentech, Sumitomo Pharma Oncology, GamaMabs Pharma, Qilu Pharmaceutical, Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., PharmaMar, Suzhou Zelgen Biopharmaceuticals, Innovent Biologics, Sinomab, Yooyoung Pharmaceutical, Amal Therapeutics, Celleron Therapeutics, Merck Sharp & Dohme Corp, and others.

Metastatic Colorectal Cancer Pipeline Analysis:

The Metastatic Colorectal Cancer pipeline report provides insights into

The report provides detailed insights about companies that are developing therapies for the treatment of Metastatic Colorectal Cancer with aggregate therapies developed by each company for the same.
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Metastatic Colorectal Cancer Treatment.
Metastatic Colorectal Cancer key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
Metastatic Colorectal Cancer Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Metastatic Colorectal Cancer market.

The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Metastatic Colorectal Cancer drugs and therapies

Metastatic Colorectal Cancer Pipeline Market Drivers

Emergence of targeted therapies for mCRC treatment, technical Advancement in molecular subtyping of CRC tumors, increase in product development activities are some of the important factors that are fueling the Metastatic Colorectal Cancer Market.

Metastatic Colorectal Cancer Pipeline Market Barriers

However, limitations in understanding secondary resistance, challenges related to precision oncology in mCRC management and other factors are creating obstacles in the Metastatic Colorectal Cancer Market growth.

Scope of Metastatic Colorectal Cancer Pipeline Drug Insight

Coverage: Global
Key Metastatic Colorectal Cancer Companies: Plus Therapeutics, Processa Pharmaceuticals, Shanghai Henlius Biotech, Genor Biopharma, Novartis Pharmaceutical, Sumitomo Pharma Oncology, Purple Biotech Ltd., Nektar Therapeutics, ALX Oncology Inc., Sunshine Guojian Pharmaceutical, Daiichi Sankyo, Gritstone Bio, Inc, Suzhou Suncadia Biopharmaceuti cals Co., Ltd, Amgen, G1 Therapeutic s, Inc., and others
Key Metastatic Colorectal Cancer Therapies: 188RNL-BAM, PCS11T, HLX13, Geptanolimab, HDM201, TP-1454, NT219, NKTR-255, Evorpacept (ALX148), CPGJ 602, Trastuzumab deruxtecan, GRT-C901, SHR-1701, Lumakras (sotorasib), Trilaciclib, and others
Metastatic Colorectal Cancer Therapeutic Assessment: Metastatic Colorectal Cancer current marketed and Metastatic Colorectal Cancer emerging therapies
Metastatic Colorectal Cancer Market Dynamics: Metastatic Colorectal Cancer market drivers and Metastatic Colorectal Cancer market barriers

Request for Sample PDF Report for Metastatic Colorectal Cancer Pipeline Assessment and clinical trials

Table of Contents

1. Metastatic Colorectal Cancer Report Introduction

2. Metastatic Colorectal Cancer Executive Summary

3. Metastatic Colorectal Cancer Overview

4. Metastatic Colorectal Cancer- Analytical Perspective In-depth Commercial Assessment

5. Metastatic Colorectal Cancer Pipeline Therapeutics

6. Metastatic Colorectal Cancer Late Stage Products (Phase II/III)

7. Metastatic Colorectal Cancer Mid Stage Products (Phase II)

8. Metastatic Colorectal Cancer Early Stage Products (Phase I)

9. Metastatic Colorectal Cancer Preclinical Stage Products

10. Metastatic Colorectal Cancer Therapeutics Assessment

11. Metastatic Colorectal Cancer Inactive Products

12. Company-University Collaborations (Licensing/Partnering) Analysis

13. Metastatic Colorectal Cancer Key Companies

14. Metastatic Colorectal Cancer Key Products

15. Metastatic Colorectal Cancer Unmet Needs

16 . Metastatic Colorectal Cancer Market Drivers and Barriers

17. Metastatic Colorectal Cancer Future Perspectives and Conclusion

18. Metastatic Colorectal Cancer Analyst Views

19. Appendix

20. About DelveInsight

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Metastatic Colorectal Cancer Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Daiichi Sankyo Company, Mirati Therapeutics, Apollomics, Treos

DTC Production Company Returns with Award-Winning Thriller/Drama “Deadly Retreat” – Now Streaming on Multiple Platforms

DTC Production Company, of Loganville, GA, renowned for their exceptional storytelling and innovative filmmaking, has once again raised the bar with their latest award-winning project, “Deadly Retreat”. This gripping Thriller/Drama, written and directed by Catina R. Fletcher and Denisha Brown Mitchell, stars an outstanding ensemble including Sir Ervin Williams, BlaQue Pearl, Anthony Gibson, Davon Smith, Xica Brewer, Shea Allen, and Zachary Jones. The film is currently available to stream on Amazon Prime Video, along with numerous other digital platforms.

“Deadly Retreat” is a masterful exploration of suspense, deception, and survival that keeps viewers on the edge of their seats from start to finish. The film’s compelling narrative and stellar performances have garnered critical acclaim, earning it multiple awards at prestigious film festivals.

DTC Production’s dedication to quality storytelling and cinematic excellence continues to resonate with audiences worldwide.

In addition to “Deadly Retreat” , DTC Production boasts a successful lineup of award-winning television series that have captivated viewers and critics alike. Their commitment to quality content and extraordinary talent has positioned them as a leading force in independent filmmaking and television production.

Aspiring actors and creative professionals interested in joining the DTC family can explore casting opportunities and connect with the team by visiting their official website at [DTC Production) (https://www.dtcproduction.com). DTC consistently seeks fresh talent to bring new stories to life and encourages passionate individuals to get involved.

Follow DTC Production Company on Instagram to stay updated on their projects, behind-the-scenes insights, casting calls, and more:

https://www.instagram.com/dtc_production_?igsh=azNnMmhpbGJyYmM3&utm_source=qr

With a proven track record of creating award-winning content and pushing creative boundaries, DTC Production continues to be a dynamic and innovative leader in the entertainment industry. Their latest release, “Deadly Retreat” , exemplifies their commitment to delivering compelling stories that entertain, provoke, and inspire audiences around the globe.

For press inquiries, interviews, or more information about DTC Production Company, please contact:

Join DTC in celebrating the success of “Deadly Retreat” and stay tuned for upcoming projects that promise to captivate audiences and showcase new talent.

About DTC Production Company

DTC Production Company is an award-winning film and television production firm dedicated to producing captivating and innovative content. Known for their compelling storytelling, diverse cast, and dedication to excellence, DTC continues to make significant impacts in the entertainment industry with their cutting-edge projects.

Media Contact
Company Name: DTC Production Company
Contact Person: Catina R. Fletcher
Email: Send Email
Country: United States
Website: www.dtcproduction.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: DTC Production Company Returns with Award-Winning Thriller/Drama “Deadly Retreat” – Now Streaming on Multiple Platforms

Ultra Air Cooler Review: The Best Portable Air Conditioner of 2025

If you’re searching for a smarter, portable, and energy-efficient way to stay cool this summer, the Ultra Air Cooler may be the perfect solution. Designed with Insta-Frost Technology, this compact, rechargeable device transforms hot, dry air into a refreshing, cold breeze without the high energy costs or bulky setup of traditional air conditioning systems.

In this in-depth review, we’ll explore how the Ultra Air Cooler works, its key features and benefits, and why it’s quickly becoming a top-rated personal cooling solution across the globe.

The Ultra Air Cooler is a portable air chiller that uses evaporative cooling to naturally lower the air temperature around you. It’s ideal for personal use in bedrooms, offices, kitchens, dorms, or even outdoor patios.

Unlike large, expensive AC units, the Ultra Air Cooler is lightweight, USB-rechargeable, and eco-friendly. With its 550ml water tank, the unit pulls in hot air, runs it through a water-saturated sponge cartridge, and releases cool, moist air instantly. Thanks to Insta-Frost Technology, you get a quick drop in temperature right where you need it.

Ultra Air Cooler Quick Specs:

Cooling Method: Evaporative cooling with Insta-Frost Technology
Tank Size: 550ml
Battery Life: 3.5 hours (rechargeable) / 8-12 hours plugged in
Fan Speeds: 3 levels
Night Light: 7 color options + off mode
Filter: Sponge cartridge, replace every 1–3 months
Weight: Lightweight and portable
Warranty: Satisfaction Guaranteed

The Ultra Air Cooler operates on Insta-Frost evaporative cooling technology, which uses water and airflow to reduce ambient temperature. Here’s a breakdown of the process:

Water Absorption: You fill the 550ml tank with clean water.
Fan Draws in Warm Air: The built-in fan pulls in hot, dry air from the environment.
Evaporation Begins: Air passes through a moisture-rich sponge filter cartridge.
Cool Air Output: The resulting airflow is cooler and more humid perfect for dry, hot conditions.

Three key factors influence the cooling effect:

Outside air temperature
Humidity levels
Device speed setting

It’s especially effective in dry climates where evaporative cooling has the most impact.

Rechargeable and Long-Lasting Performance

One of the Ultra Air Cooler’s standout features is its rechargeable battery. Simply use the included USB cable to charge the unit. A blinking light will indicate charging, and a solid light shows when the device is fully charged.

Here’s what you can expect in terms of runtime:

On battery power: Lasts up to 3.5 hours depending on speed, room temp, and humidity
When plugged in: Delivers 8 to 12 hours of continuous cooling on a single water fill

This dual power option makes it versatile enough for indoor and outdoor use.

Key Features of the Ultra Air Cooler

• Insta-Frost Technology Delivers fast, evaporative cooling that’s efficient and environmentally friendly.

• USB Rechargeable Runs on battery or plugged in great for desks, bedside tables, patios, and RVs.

• Three-Speed Fan Settings Low, medium, and high-speed options let you personalize the airflow.

• 550ml Water Tank Large enough to last several hours without frequent refills.

• Color-Changing LED Night Light Choose from Blue, Red, White, Teal, Purple, Yellow, Green, or Color Cycle. You can also turn the light off by cycling through all options.

• Eco-Friendly Cooling Cartridge Made from a sponge material that lasts 1–3 months based on usage. Note: there’s no indicator for when to replace it, so keep an eye on performance.

• Ultra Quiet Operation Whisper-quiet fan won’t disturb your sleep, work, or conversations.

• Compact & Lightweight Perfect for small rooms, camping trips, or workspaces without air conditioning.

Ultra Air Cooler Benefits

Portable Comfort: Move it from room to room with ease.
Energy Savings: Avoid the high electricity costs of a central AC system.
Healthier Air: Humidifies dry environments and traps dust and allergens.
Environmentally Friendly: No refrigerants, chemicals, or carbon-heavy impact.
Quick Setup: No installation required just add water and turn it on.

The Ultra Air Cooler is available for a limited-time 50% discount directly from the manufacturer. Here are the current pricing options. Ultra Air Cooler offers a tiered pricing structure designed to provide significant savings based on the quantity purchased. A single unit is available for $89.99, reduced from the original price of $179.98, offering a 50% discount. Opting for two units brings the price to $179.98, down from $359.96, while purchasing three units costs $199.98, a substantial reduction from the original $399.96. Each option includes fast USA shipping, ensuring prompt delivery.

Media Contact
Company Name: Ultra Air Cooler
Contact Person: Media Relations
Email: Send Email
Country: United States
Website: https://bit.ly/3qGek75

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Ultra Air Cooler Review: The Best Portable Air Conditioner of 2025

A Provocative New Thriller Challenges the Boundaries of Justice: Capital Punishment: An Eye for an Eye by Tom Cooke Debuts to Stirring Acclaim

In a gripping tale that merges cutting-edge science with raw emotional power, debut author Tom Cooke unveils Capital Punishment: An Eye for an Eye—a bold and thought-provoking novel that asks: when the justice system fails, how far would you go to make things right?

Set in a near-future America plagued by rising crime and a broken justice system, the story centers on Henry “Hank” Mulenbeck, a brilliant engineer whose life is turned upside down by a brutal tragedy. Consumed by grief, Hank pioneers an advanced system of robotic enforcers—CloBots—designed to deliver a controversial brand of justice: punishments that mirror the crimes committed.

As CloBots deliver swift and equal justice, society appears to transform—until a new wave of crime surfaces, darker and more elusive than ever before. What follows is a chilling descent into a moral quagmire, where the distinction between hero and executioner blurs, and the cost of retribution may prove too high.

“Capital Punishment explores the haunting intersection of technology, justice, and vengeance,” says Cooke. “It’s a high-stakes story about loss, responsibility, and the choices we make when systems we trust collapse around us.”

With sharp storytelling and emotionally driven suspense, Capital Punishment: An Eye for an Eye is a powerful debut that confronts readers with urgent ethical questions and keeps them turning pages late into the night.

About the Author

Tom Cooke is a debut novelist with a distinct voice and a passion for exploring themes of justice, morality, and human resilience. With Capital Punishment: An Eye for an Eye, Cooke delivers a deeply personal yet universally resonant story that challenges conventional boundaries and invites powerful reflection.

Media Contact
Company Name: Book Writing Maestros
Contact Person: Tom Cooke
Email: Send Email
Phone: 4176672286
Address:319 N Elizabeth St
City: NEVADA
State: Missouri
Country: United States
Website: https://www.bookwritingmaestros.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: A Provocative New Thriller Challenges the Boundaries of Justice: Capital Punishment: An Eye for an Eye by Tom Cooke Debuts to Stirring Acclaim

The Incredible Power of Publicity for Authors

Plymouth, MI, USA – May 8, 2025 – Sometimes it’s luck, sometimes it’s the right timing, but the real secret to a book’s success is publicity. Book Publicist Scott Lorenz is an expert in the field, helping hundreds of authors to push their work into the mainstream. But what is publicity, and why does it work so well? “It is not the same as advertising or marketing. Publicity happens much more organically, and it can be the key factor for an author’s big break,” Lorenz says. His article The Incredible Power of Publicity for Authors is a testament to his knowledge and provides resources and advice for authors.

Publicity often begins with a campaign; this can include press kits, interviews, trailers, and more, but the main goal is clear: get people talking. True publicity starts there. “Interviews on podcasts, radio, TV, and print help truly motivated book readers to buy a book. If they like an author interview, they’ll read the synopsis, check out the reviews, and then buy the book. If they like it, those book buyers become advocates themselves and tell their friends, family, and associates,” Lorenz says. “For authors, there are tons of resources out there for publicity. Hiring agents, using social media, and traditional marketing are just some first steps.”

Some noteworthy examples Lorenz highlights include British spy author Mick Herron, who got his big break through a raving review on public radio, Dan Brown, who changed the focus of his publicity by painting a new image of himself, and Rachel Ray, who used a radio show promoting her cookbooks to launch her tv career. Scott Lorenz also recalls a personal example: Jared Knott, whose work received little attention until Lorenz’s company pushed him into the limelight through press kits, a book trailer, and dozens of interviews. Publicity works, and Lorenz has the proof to back it!

“Word-of-Mouth IS FREE but it takes a financial commitment from the author or publisher to get the publicity going so that word-of-mouth can do its work,” Lorenz says.

For all your book publicity needs, check out his website or his blog.

About Book Publicist Scott Lorenz

Book publicist Scott Lorenz is President of Westwind Book Marketing, a public relations and marketing firm that has a special knack for working with authors to help them get all the publicity they deserve and more. Lorenz works with bestselling authors and self-published authors promoting all types of books, whether it’s their first book or their 15th book. He’s handled publicity for books by CEOs, CIA Officers, Navy SEALS, Homemakers, Fitness Gurus, Doctors, Lawyers and Adventurers. His clients have been featured by Good Morning America, FOX & Friends, CNN, ABC News, New York Times, Nightline, TIME, PBS, LA Times, USA Today, Washington Post, Woman’s World, & Howard Stern to name a few.

Learn more about Westwind Book Marketing at www.WestwindBookMarketing.com or contact Lorenz at scottlorenz@westwindcos.com or 734-667-2090. Want help titling a book? Check out Scott Lorenz’s new award-winning, bestselling book: Book Title Generator: A Proven System in Naming Your Book or www.BookTitleGenerator.net.

Media Contact
Company Name: Westwind Communications Book Marketing
Contact Person: Scott Lorenz
Email: Send Email
Phone: 248-705-2214
Country: United States
Website: https://www.WestwindBookMarketing.com

A Thrilling Sequel to An Award-Winning Book: Laurie Elizabeth Murphy Captivates Readers in Dream Me Dead

“Most people think that death is final. Most people are wrong.”

Stuart, FL, USA – May 8, 2025 – Following the events of her hit book Dream Me Home, author Laurie Elizabeth Murphy continues the thrilling story in the sequel, Dream Me Dead. It involves a fascinating court case, a tangled web of relationships, all culminating in a twist ending that will leave readers wanting more.

There’s nothing as compelling as a courtroom drama and Laurie Elizabeth Murphy’s new novel has courtroom drama in spades. The book is definitely a page turner and you won’t want to put it down as you see the mystery unfold.

John Kelly, Detroit Free Press

In her first book, we are introduced to Peggy Prescott, a woman found in dead in her bed of seemingly hypothermia. In the months leading up to her death, Peggy was meeting with a therapist, whom she revealed to that she had been having dreams of a mysterious man in a parallel universe. However, the odd circumstances surrounding her death, including her dreams, her husband, and a wide cast of colorful characters with motive, leave questions unanswered, even when Peggy is at peace.

Murphy’s impressive descriptive skills, imbued with her insights into both psychology and relationship/marital facets, brings a new level of achievement to the literary realm. This book, from start to finish, is completely involving, one that challenges the reader once started, to read to the end. One of the finest mystery thrillers this reviewer has encountered!

Grady Harp, Amazon Top 100 Hall of Fame Reviewer

Dream Me Dead picks up with Peggy’s husband, Rob, on trial for her murder. Accompanied by a lawyer who is unsure of his innocence and people who have reason to put the blame on him, Rob navigates the aftermath of losing his wife, his crumbling family, and possibility of going to jail over a crime he didn’t commit. Dream Me Dead takes us back through the cast of characters from the first book and their intertwining stories. The biggest mysteries are these: What misdeeds is Rob guilty of, what really happened to Peggy Prescott, and can it hold up in a court of law, no matter how absurd the real answer seems?

Laurie Elizabeth Murphy is a talented author who has won a multitude of awards for her books, and her history in the psychology field helps bring these characters to life, giving them realistic thoughts, motives, and opinions.

Lauren Lee, Writer and Editor

For fans of crime and mystery, Dream Me Dead is the perfect sequel to a psychological thriller. Laurie Elizabeth Murphy has decades of experience as a psychotherapist, and it is reflected through the way she portrays the deep inner workings of the mind. She won a variety of awards for Dream Me Home, including those from the PenCraft Book Awards and the Outstanding Creator Awards. Dream Me Dead is the much-anticipated continuation of her talent and is certain to be a sensation for years to come!

Buy the book on Amazon, Barnes and Noble and her website: https://www.lauriemurphy.net (ASIN: B0F1WG5JHK)

About Laurie Elizabeth Murphy: Laurie is a full-time author of both non-fiction and fiction books. She previously worked as a Registered Nurse and Psychology Counselor with degrees from the Mount Sinai Hospital School of Nursing and St. Joseph’s College. Growing up, she was a ballet student at the MET in New York City and The Juilliard School of Music and Dance. She currently resides in Florida, and she has four children and six grandchildren.

She has published many nonfiction books, co-authoring with her late husband to write In the Best Interest of the Child: A Manual for Divorcing Parents, Eight Strategies for Successful Step-Parenting, and You Don’t Know Anything: A Manual for Parenting Teenagers. She has also written and self-published Satori, Wherever the Wind Blows Me, and Cellophane Memories. Additionally, she writes a bi-monthly column for My Living, a local magazine. Her hit novel Dream Me Home has won a variety of awards, including the PenCraft Book Award for Best Fiction in the Mystery-Sleuth category, the Literary Titan Silver Book Award for the best fiction book in the Romantic Suspense/Thriller genre, and eight wins from The Outstanding Creator Awards.

Media Contact: For a review copy of Dream Me Dead or to arrange an interview with Laurie Elizabeth Murphy, contact Scott Lorenz of Westwind Book Marketing at scottlorenz@westwindcos.com or by phone at 248-705-2214. Reach Lorenz on Twitter @abookpublicist.

Post Truth: The first feature-length AI film in the world to receive theatrical release

Alkan Avcıoğlu: “Post Truth questions the very foundations of reality and the narratives we choose to believe in.

Described as “a fake film about the real world,” Post Truth explores our relationship with technology and how we arrived at a cultural moment where truth and reality no longer matter. The film documents an era of endless information overload and dissonance, using the very language of the era it reflects.

ISTANBUL, Turkey – May 8, 2025 – Post Truth, the first feature-length documentary entirely generated using artificial intelligence, has secured a wide theatrical release—becoming the first AI film in history to reach cinemas.

Distributed by Baska Sinema, Turkey’s leading distributor for independent cinema, the English-language film will open this summer across more than 20 cities. The release was first reported in Deadline, marking a landmark moment in the evolution of filmmaking. Created by pioneering generative AI artist Alkan Avcıoğlu, the film is already drawing strong international interest from festivals and distributors, sparking discussions about the future of cinema.

Described as “a fake film about the real world,” Post Truth explores our relationship with technology and how we arrived at a cultural moment where truth and reality no longer matter. The film documents an era of endless information overload and dissonance, using the very language of the era it reflects.

“We live in an era where everything feels staged and unreal—from politics to social media,” says director Alkan Avcıoğlu. “Post Truth questions the very foundations of reality and the narratives we choose to believe in.”

Avcıoğlu worked in the film industry for over a decade before leaving his career behind to become an artist, exploring new storytelling possibilities through artificial intelligence. That decision established him as a leading voice in the art scene, with works questioning photographic reality. He became one of the first AI artists to be accepted into major traditional art fairs, including Paris Photo, Art Basel Miami, Zona Maco, and Vogue Photo. His work has been auctioned by Christie’s New York and exhibited worldwide at galleries.

The film’s script, co-written and co-produced with multidisciplinary artist Vikki Bardot, draws inspiration from the large-scale cinematic vision of Godfrey Reggio and the archival essay style of Adam Curtis and Chris Marker. Developed over 15 months, the project draws from a pool of more than 55 hours of AI-generated material, totaling over 200,000 seconds of synthetic imagery and sound. Emerging from Avcıoğlu’s established style and conceptual framework, the visuals, sound, music, and voice are fully created through artificial intelligence.

“Post Truth marks a new frontier for filmmaking: not just in how films are made, but in how reality itself is represented on screen.” commented Vikki Bardot, who co-produced the film through Spongeworthy Studio. “Storytelling today must speak in the visual language of a world where real and fake have already merged.”

Backed by Başka Sinema, Post Truth is poised to become a milestone in the evolving language of filmmaking, as it ventures into the era of machine-generated image-making. “We believe it’s important to acknowledge and understand how new tools like AI are expanding the language of cinema in real time,” said Armağan Lale, Director of Başka Sinema. The company is preparing to be in talks with international distributors and sales agents in the upcoming Cannes Film Festival.

Video Link: https://www.youtube.com/embed/tmpHlf3nMoQ

To view the original version on DWPR visit: Post Truth – The First Feature-Length AI Film in the World to Receive Theatrical Release

Media Contact
Company Name: Baska Sinema
Contact Person: BEYZA BUYUK
Email: Send Email
Country: Turkey
Website: https://www.baskasinema.com

EXEED Unveils AiMOGA Intelligent Robots and ES Performance Edition at Shanghai Auto Show, Pioneering a New Era of Smart and Performance-Driven Innovation

Global premium automotive brand EXEED made a striking appearance at the 2025 Shanghai Auto Show under the theme “Shift To Tomorrow,” unveiling its three major new energy models—ET, ES, and RX PHEV—alongside its self-developed AiMOGA intelligent robots.

As a highlight of the press conference, EXEED showcased the AiMOGA robots’ “multi-robot collaboration” capabilities for the first time, demonstrating the brand’s leadership in intelligent technology. Meanwhile, the global debut of the ES Performance Edition drew widespread attention from media and audiences, impressing with its aggressive race-inspired design and outstanding performance.

EXEED Accelerates AI Robot Development, Ushering in the Era of Intelligent Mobility

EXEED began humanoid robot research and development as early as 2020. In 2023, the company officially released its self-developed robot and robotic dog ecosystem products.

In 2024, EXEED announced an investment of over AED 100 million to accelerate its robotics business, which has now entered the mass production phase. During the Shanghai Auto Show, AiMOGA robots successfully completed a “multi-robot collaboration” demonstration, marking a major milestone in EXEED’s robotics journey and paving the way for further breakthroughs in intelligent mobility.

Upgraded Multi-Robot Coordination: “One Command, Multiple Robots Collaboration”

“In the past, one robot would receive and execute voice commands; today, one robot understands your instructions and coordinates multiple robots to complete tasks,” explained the AiMOGA Intelligent System lead.

At the show, audiences witnessed a “multi-robot squad” of three robots, executing tasks such as welcoming guests, delivering water, and providing directions, based on a unified large model framework for language understanding and task scheduling.

Achieving this “multi-robot one-brain” coordination was a major technical challenge. To overcome it, the team developed a scheduling algorithm integrated with a large model mechanism, enabling the robots to receive and execute unified commands with flexible task division—much like a coordinated workgroup.

Qin Chao, CEO of EXEED, stated: “EXEED is not only focused on robotics development but also applies breakthroughs in language interaction and AI technology to our high-end vehicles, creating a ‘human-vehicle-robot’ intelligent mobility ecosystem for an even smarter and more convenient user experience.”

Global Debut of the ES Performance Edition

At the EXEED press conference, the ES Performance Edition made a stunning debut, building upon the “Nature’s Power” design philosophy while deeply integrating the brand’s performance DNA.

In terms of design, the ES Performance Edition introduces extensive track-grade aerodynamic enhancements to its streamlined fastback silhouette. This ensures it maintains the industry-leading acceleration of 0–100 km/h in just 3.7 seconds, while also delivering sharper handling and a more aggressive, performance-focused aesthetic.

Lightweight construction was pushed to the extreme with widespread use of carbon fiber in key areas—including the grille, hood, side skirts, rear wing, and rear diffuser. A full carbon-fiber hood with a large ventilation outlet, carefully placed aerodynamic blades across the body, and an adjustable two-stage rear wing combine to craft EXEED’s distinctive performance coupe identity.

At speeds of up to 210 km/h, the rear wing generates 110 kilograms of downforce, significantly enhancing road adhesion and high-speed stability.

The ES Performance Edition also makes a bold statement with its “Pulse Green” metallic fluorescent paint. The high-saturation fluorescent base, infused with shimmering multicolored particles, reveals a radiant golden pulse under strong light, while transforming into a mysterious dark green in shadow. The shifting metallic particles create a dynamic “breathing” effect, delivering a visually stunning, pulse-like impact that brings the vehicle vividly to life.

The UAE is the launch market for EXLANTIX. It is reported that EXEED plans to expand into high-regulation markets, including European countries such as Norway and Denmark, and will gradually launch a series of track tour test drive events across global markets.

Media Contact
Company Name: YallaMotor
Contact Person: Mostafa ELMissary
Email: Send Email
Phone: 0508841610
Address:Jumeriah Village St – 1 Lazuward S W, Tower 108, apartment 1212
City: JVC
Country: United Arab Emirates
Website: https://www.yallamotor.com/